Small Molecule Drug Product CDMO Benchmarking (8th Ed.)

Report Overview

ISR’s Small Molecule Drug Product CDMO Benchmarking (8th Edition) report brings with it a wealth of information, created with two goals in mind: to help biopharmaceutical companies make more informed CDMO decisions, and to help CDMO’s optimize operational and marketing strategies.

This report provides biopharma companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality across a series of 24 performance attributes specific to outsourced drug product manufacturing. In this Consumer Reports-style analysis, ISR presents data on 528 service encounters from 140 respondents who have been involved in outsourced drug product projects in the past 18 months.

What you will learn:

Drug Developers:

• Make a more educated purchase of CDMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CDMOs have measured up to sponsor-peer expectations on similar projects
• Uncover which CDMO attributes drive outsourcing partner selection for drug product manufacturing as well as which CDMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CDMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Contract Manufacturers:

• Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
• Compare your company’s performance against its competitors across 24 performance metrics specific to outsourced drug product manufacturing and related services
• Gain insight into drug developers’ outsourcing preferences and practices with respect to CDMO selection and CDMO preference for outsourced small molecule drug product manufacturing

Major Sections:

• Outsourcing Philosophies & Practices
• CDMO Selection Drivers
• CDMO Perceptions & Interactions
• CDMO Performance & Loyalty
• The Small Molecule Drug Product CDMO Competitive Landscape
• Company Service Quality Profiles
• Appendix
• CDMO Drill-Downs
• Demographics

Included Providers:

• AbbVie Contract Manufacturing
• Adare Pharma Solutions
• Alcami
• Almac
• Ardena
• Bend Bioscience
• Bora
• BSP Pharmaceuticals
• Carbogen Amcis
• Catalent
• Cenexi
• Coating Place
• Corden Pharma
• Curia
• DPT
• Evonik
• Evotec
• Famar
• Fareva
• Formulated Solutions
• Glatt Pharmaceutical Services
• Grifols
• GSK Contract Manufacturing
• Hetero
• Hovione
• Kindeva Drug Delivery
• Lonza
• MilliporeSigma
• Nanoform
• NextPharma
• Pace Analytical
• Patheon, by Thermo Fisher Scientific
• PCI Pharma Services
• Pfizer CentreOne
• Piramal Pharma Solutions
• Pyramid Laboratories
• Quotient Sciences
• Recipharm
• Resilience
• Seran
• Siegfried
• Sterling Pharma Services
• Unither Pharmaceuticals
• Vectura
• Vetter
• Wockhardt
• WuXi STA

Companies listed in bold print have been reviewed by 10 or more respondents. These providers have detailed company service quality profiles and are included in an in-depth performance analysis.